StockNews.AI
HHS
StockNews.AI
78 days

Harte Hanks Acquires Exclusive Rights to License ADS Data Direct's Premier Medical Ailment Database

1. Harte Hanks secured exclusive licensing for ADS's Medical Ailment Database. 2. The database enhances targeting precision for healthcare marketers. 3. It includes data on 200+ health conditions, ensuring compliance and reliability. 4. Investment in health data solutions strengthens HHS's market position. 5. This milestone reflects a commitment to ethical marketing practices.

M&A
-9.75%Current Return
VS
+1.2%S&P 500
$4.7206/02 11:04 AM EDTEvent Start
$4.2606/03 05:20 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

The acquisition of exclusive licensing enhances HHS's competitive edge in a growing market. Historical trends show that enhanced data capabilities lead to increased client engagement and revenue growth.

How important is it?

The licensing agreement significantly boosts HHS's market capabilities and positions it well for future opportunities. Data-driven marketing is pivotal for growth in the healthcare sector.

Why Long Term?

This strategic move is expected to yield sustained benefits as healthcare marketing becomes increasingly data-driven over the next several years. Similar acquisitions in the past have provided long-term revenue boosts.

Related Companies

ADSCRMIQVCERNRMD
Strategic Licensing Rights Strengthen Harte Hanks' Leadership in Compliant, High-Precision Healthcare Marketing Harte Hanks (NASDAQ:HHS), a global leader in customer experience and data-driven marketing, today announced that it has obtained exclusive rights to license ADS Data Direct's (ADS) industry-leading Medical Ailment Database, with limited client exceptions. This transformative undertaking positions Harte Hanks as the controller of one of the most comprehensive, HIPAA-compliant health data assets available in the market, delivering unmatched value to healthcare marketers.ADS's Medical Ailment Database, sourced through the Healthier Me Today platform, provides access to 100% triple opt-in consumers who have self-identified as living with specific health conditions across more than 200 ailment categories. This valuable data asset enhances Harte Hanks' ability to deliver superior targeting precision, campaign performance, and compliance assurance for clients in the pharmaceutical, medical device, and broader healthcare sectors."The exclusive licensing right to this high-integrity database is a strategic milestone for Harte Hanks, deepening our commitment to delivering unparalleled data solutions that empower healthcare and health-related marketers," said Teresa Gavin, VP of Data Solutions at Harte Hanks. "We are now better positioned than ever to help our clients engage the right consumers-ethically, effectively, and with measurable impact."The Medical Ailment Database is distinguished by its depth and reliability, capturing self-reported health data through rigorous HIPAA-compliant processes on the Healthier Me Today platform. It is purpose-built to support campaigns targeting individuals managing conditions such as diabetes, arthritis, heart disease, mental health disorders, and many more.ADS is a premium provider of precision-targeted marketing solutions, offering proprietary data assets that drive scalable lead generation and engagement strategies across digital, mobile, email, and direct mail channels."Harte Hanks' licensing rights to our flagship health database reflects their vision and leadership in data-driven marketing," said Eric Nelson, President & Managing Partner of ADS Data Direct. "We are confident that their expertise and strategic focus will unlock the full potential of this asset, delivering exceptional value to healthcare and health-related marketers."For media inquiries or to learn more about the Medical Ailment Database, please contact:Cindy SteinGlobal Head of MarketingHarte Hanks[email protected]www.HarteHanks.comSOURCE: Harte Hanks, Inc.

Related News